Leaders rotate: why a portfolio needs calibrating, not just choosing
For most of 2026, technology led: chip stocks were up about 45% for the year and the AIA Global Technology Fund about 22.5%. Then in October the leadership flipped. Over the month to 27 Oct the AIA Global Technology Fund fell 5.9% while the AIA International Health Care Fund rose 4.8%, and in the last week of October Alphabet and Intel had their worst days in decades while health care, energy and consumer staples rose. A portfolio set up in January and left alone would have drifted heavily into tech just before the drop.
Diversification sets the mix; calibration keeps it. Winners grow into a bigger share of the portfolio than intended, so regular reviews (trimming what ran, topping up what lagged) keep risk where the client chose it.
The numbers
- AIA Global Technology Fund −5.9% vs AIA International Health Care Fund +4.8%, 1 month to 27 Oct 2026 (FAT)
- YTD to 27 Oct 2026: AIA Global Technology +22.5%, AIA International Health Care +10.8% (FAT)
- 1 month to 30 Oct 2026: US tech ETF XLK −9.3%, chips SMH −15.4%; health care XLV +11.2%, energy XLE +11.7%, staples XLP +11.3%
- 30 Oct 2026: XLK −4.9%, SMH −7.0% vs XLE +1.9%, XLP +1.4%, XLV +0.5%
- Alphabet −12.6% on 29 Oct 2026; Intel −29% on 30 Oct 2026
Sources: cnbc.com · cnbc.com · cnbc.com · AIA fund prices · finance.yahoo.com